Citations

Mayo Clinic

Showing 10 of 108522 citations.

Current and Novel Treatment Options in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
Lopetegui‐Lia, Nerea , Varma, Revati , Abraham, Jame , Roesch, Erin , Varma, Revati

JCO Oncology Practice | August 22, 2024 | Volume: 21 | Issue: 2 | Pages: 145-154

10.1200/op.23.00830 | PMID 39167745 Get It

Metastatic breast cancer (mBC) remains an incurable disease, and most patients will experience disease progression during their treatment course. Although endocrine therapy remains the mainstay of treatment for hormone receptor–positive/human epidermal growth factor receptor 2–negative mBC, significant progress has been and continues to be made in the treatment of this BC subtype. The discovery of molecular markers, mutations in key cellular pathways, and genomic signatures have led to the development of novel and targeted agents, such as antibody-drug conjugates, oral selective estrogen receptor downregulators, and inhibitors of the PI3K/AKT/mTOR pathway. This has resulted in significant improvements in the survival and quality of life of patients. With the increasing number of treatment options for patients, appropriate drug sequencing remains a challenge. Treatment discussions should involve patient-physician shared decision making, with consideration of genomic data, previous lines of therapy, side effect profiles, and clinical trial enrollment.
Time to unlock pain relief? A critical review of the patient-controlled analgesia 4-hour lockout parameter
Kiel, Alexander , Warner, Nafisseh S. , Smith, N., Kiel, Alexander M , Smith, Nathan T. , Warner, Nafisseh

Pain Medicine | August 21, 2024 | Volume: 26 | Issue: 1 | Pages: 1-2

10.1093/pm/pnae087 | PMID 39167117 Get It

Can optical evaluation distinguish between T1a and T1b esophageal adenocarcinoma: an international expert interobserver agreement study
Gupta, Sunil , Mandarino, Francesco Vito , Hourigan, Luke F. , Messmann, Helmut , Wallace, Michael B. , Repici, Alessandro , Haber, Gregory , Taylor, Andrew C.F., Waxman, Irving , Siersema, Peter D. , Lemmers, Arnaud , Bisschops, Raf , Mosko, Jeffrey D. , Pech, Oliver , Beyna, Torsten , Sharma, Prateek , Lee, Eric Y.T., Bourke, Michael J., group, on behalf of the study working, Bourke, Michael J. , Shahidi, Neal , Wallace, Michael B , Bisschops, Raf , Beyna, Torsten , Burgess, Nicholas G , Mandarino, Francesco Vito , Gupta, Sunil , Dinis‐Ribeiro, Mário , Pouw, Roos E. , Teshima, Christopher , Ragunath, Krish , Rösch, Thomas , group, on behalf of the study working

Endoscopy | August 21, 2024 | Volume: 57 | Issue: 03 | Pages: 200-207

10.1055/a-2399-1401 | PMID 39168143 Get It

Background Piecemeal endoscopic mucosal resection (EMR) is an acceptable technique for T1a esophageal adenocarcinoma, but en bloc R0 excision is advocated for T1b disease as it may offer a potential cure and mitigate recurrence. Thus, distinguishing between T1a and T1b disease is imperative under current treatment paradigms. We investigated whether expert Barrett’s endoscopists could make this distinction based on optical evaluation. Methods Endoscopic images of histologically confirmed high grade dysplasia (HGD), T1a, and T1b disease (20 sets for each) were compiled from consecutive patients at a single institution. Each set contained four images including an overview, a close-up in high definition white light, a near-focus magnification image, and a narrow-band image. Experts predicted the histology for each set. Results 19 experts from 8 countries (Australia, USA, Italy, Netherlands, Germany, Canada, Belgium, and Portugal) participated. The majority had been practicing for > 20 years, with a median (interquartile range) annual case volume of 50 (18–75) for Barrett’s EMR and 25 (10–45) for Barrett’s endoscopic submucosal dissection. Esophageal adenocarcinoma (T1a/b) could be distinguished from HGD with a pooled sensitivity of 89.1 % (95 %CI 84.7–93.4). T1b adenocarcinoma could be predicted with a pooled sensitivity of 43.8 % (95 %CI 29.9–57.7). Fleiss’ kappa was 0.421 (95 %CI 0.399–0.442; P < 0.001), indicating fair-to-moderate agreement. Conclusions Expert Barrett’s endoscopists could reliably differentiate T1a/T1b esophageal adenocarcinoma from HGD. Despite fair-to-moderate agreement for T staging, T1b disease could not be reliably distinguished from T1a disease. This may impact clinical decision making and selection of endoscopic techniques.
Succinate dehydrogenase–complex II regulates skeletal muscle cellular respiration and contractility but not muscle mass in genetically induced pulmonary emphysema
Balnis, Joseph , Tufts, Ankita , Jackson, Emily , Drake, Lisa A. , Singer, Diane V. , Lacomis, David , Lee, Chun Geun , Elias, Jack A. , Doles, Jason D. , Maher, L. James, Coon, Joshua J. , Singer, Harold A. , Vincent, Catherine E., Jaitovich, Ariel, Jen, Annie , Coon, Joshua J , Jourd'heuil, David , Jaitovich, Ariel , Lacomis, David , Doles, Jason D , Drake, Lisa A.

Science Advances | August 21, 2024 | Volume: 10 | Issue: 34 | Pages: No page available

10.1126/sciadv.ado8549 | PMID 39167644 Get It

Reduced skeletal muscle mass and oxidative capacity coexist in patients with pulmonary emphysema and are independently associated with higher mortality. If reduced cellular respiration contributes to muscle atrophy in that setting remains unknown. Using a mouse with genetically induced pulmonary emphysema that recapitulates muscle dysfunction, we found that reduced activity of succinate dehydrogenase (SDH) is a hallmark of its myopathic changes. We generated an inducible, muscle-specific SDH knockout mouse that demonstrates lower mitochondrial oxygen consumption, myofiber contractility, and exercise endurance. Respirometry analyses show that in vitro complex I respiration is unaffected by loss of SDH subunit C in muscle mitochondria, which is consistent with the pulmonary emphysema animal data. SDH knockout initially causes succinate accumulation associated with a down-regulated transcriptome but modest proteome effects. Muscle mass, myofiber type composition, and overall body mass constituents remain unaltered in the transgenic mice. Thus, while SDH regulates myofiber respiration in experimental pulmonary emphysema, it does not control muscle mass or other body constituents.
Stress-induced eosinophil activation contributes to postoperative morbidity and mortality after lung resection
Mei, Zhongcheng , Khalil, May A. , Guo, Yizhan , Li, Dongge , Banerjee, Anirban , Taheri, Mojtaba , Kratzmeier, Christina , Chen, Kelly , Lau, Christine L. , Luzina, Irina G., Atamas, Sergei P. , Kandasamy, Sivaveera, Kreisel, Daniel , Jacobsen, Elizabeth A. , Krupnick, Alexander S. , Gelman, Andrew E , Jacobsen, Elizabeth A , Krupnick, Alexander Sasha , Chen, Kelly

Science Translational Medicine | August 21, 2024 | Volume: 16 | Issue: 761 | Pages: No page available

10.1126/scitranslmed.adl4222 | PMID 39167663 Get It

Respiratory failure occurs more frequently after thoracic surgery than abdominal surgery. Although the etiology for this complication is frequently attributed to underlying lung disease present in patients undergoing thoracic surgery, this notion is often unfounded because many patients with normal preoperative pulmonary function often require prolonged oxygen supplementation even after minimal resection of lung tissue. Using a murine model of pulmonary resection and peripheral blood samples from patients undergoing resection of the lung or abdominal organs, we demonstrated that lung surgery initiates a proinflammatory loop that results in damage to the remaining lung tissue, noncardiogenic pulmonary edema, hypoxia, and even death. Specifically, we demonstrated that resection of murine lung tissue increased concentrations of the homeostatic cytokine interleukin-7, which led to local and systemic activation of type 2 innate lymphoid cells. This process activated lung-resident eosinophils and facilitated stress-induced eosinophil maturation in the bone marrow in a granulocyte-macrophage colony-stimulating factor–dependent manner, resulting in systemic eosinophilia in both mice and humans. Up-regulation of inducible nitric oxide synthase in lung-resident eosinophils led to tissue nitrosylation, pulmonary edema, hypoxia, and, at times, death. Disrupting this activation cascade at any stage ameliorated deleterious outcomes and improved survival after lung resection in the mouse model. Our data suggest that repurposing US Food and Drug Administration–approved eosinophil-targeting strategies may potentially offer a therapeutic intervention to improve outcomes for patients who require lung resection for benign or malignant etiology.
Cannabis use patterns and association with hyperemesis: A comprehensive review
Alshaarawy, Omayma , Venkatesan, Thangam , Hasler, William L. , Venkatesan, Thangam

Neurogastroenterology & Motility | August 21, 2024 | Volume: 37 | Issue: 3 | Pages: No page available

10.1111/nmo.14895 | PMID 39164887 Get It

Abstract Background Cannabis use in the general population is prevalent and is rising because of increased acceptance of its use, legalization in most US states, and perceived health benefits. Cannabis product potency has dramatically increased with higher delta‐9‐tetrahydrocannabinol content. Cannabis has documented antiemetic properties and cannabinoid pharmaceuticals are used in disorders like chemotherapy‐induced nausea and vomiting. Purpose Forty to eighty percent of cyclic vomiting syndrome (CVS) patients use cannabis products, which reportedly reduce stress as well as nausea and vomiting. Cannabinoid hyperemesis syndrome (CHS) has a presentation similar to CVS, but is associated with longstanding, high dose cannabis use, and is thought to be relieved by sustained cannabis abstinence. Most CHS patients have used cannabis on a daily or near‐daily basis for more than 2 years. Compulsive hot‐water bathing behaviors are reported by most CHS patients, but are not specific for this disorder as they are also noted by about half of CVS patients. Episodic vomiting associated with cannabis use contributes to extensive health resource use, including emergency department visits and inpatient hospitalizations, and impacts patients and their families negatively. Treatment for CHS overlaps with CVS although cannabis abstinence remains the cornerstone of its management. Challenges associated with cannabis use cessation in CHS include patient skepticism of the role of cannabis as a cause of symptoms, perceived benefits of cannabis, and a lack of other effective therapies. In this review, we highlight cannabis use patterns in the US and discuss diagnosis and management of CHS and gaps in knowledge about this disorder.
Urinary Retention Following Electro-Convulsive Therapy Under General Mask Anesthesia
Stephenson, Anthony A. , Morgan, Robert J. , Schroeder, Darrell R. , Weingarten, Toby N. , Abel, Martin D, Weingarten, Toby N , Schroeder, Darrell , Abel, Martin , Šprung, Juraj , Morgan, Robert J

The Canadian Journal of Psychiatry | August 21, 2024 | Volume: 69 | Issue: 10 | Pages: 778-780

10.1177/07067437241271738 | PMID 39166343 Get It

Autoimmune Neurobeachin Cerebellar Ataxia
Basal, Eati, Gilligan, Michael , Lesnick, Connie , McKeon, Andrew

Movement Disorders | August 21, 2024 | Volume: 39 | Issue: 12 | Pages: 2271-2275

10.1002/mds.29991 | PMID 39165102 Get It

AbstractBackgroundThere are more than 30 immunoglobulin G (IgG) autoantibody biomarkers of autoimmune cerebellar ataxia reported.ObjectiveTo describe a novel IgG biomarker targeting neurobeachin, a scaffolding protein integral to synapse formation and function.MethodsClinical and laboratory‐based assessment was used for a novel diagnostic biomarker of autoimmune ataxia.ResultsA 46‐year‐old woman had ataxia onset followed by bilateral knee pain, attributable to rheumatoid arthritis. She was negative for standard neural antibodies. Her ataxia stabilized and tremor initially improved after corticosteroid treatment, but she progressed to wheelchair‐dependence (on methotrexate and then rituximab) over 4 years, in keeping with the trajectory encountered by many with autoimmune ataxia. In contrast, her inflammatory arthritis remitted with immunotherapy. Neurobeachin‐IgG was unmasked in serum and cerebrospinal fluid using protein arrays and confirmed using neurobeachin‐specific confocal immunofluorescence and Western blot.ConclusionsNeurobeachin‐IgG is a new neural antibody biomarker of cerebellar ataxia among a growing antibody repertoire, collectively common but often individually rare. © 2024 International Parkinson and Movement Disorder Society.
Automated Extraction of Patient-Centered Outcomes After Breast Cancer Treatment: An Open-Source Large Language Model–Based Toolkit
Luo, Man , Kurian, Allison W. , Ward, Kevin C. , Keegan, Theresa H.M. , Rubin, Daniel L. , Banerjee, Imon , Trivedi, Shubham , Kurian, Allison W , Ward, Kevin , Keegan, Theresa H M , Rubin, Daniel L , Banerjee, Imon

JCO Clinical Cancer Informatics | August 21, 2024 | Volume: No volume available | Issue: 8 | Pages: No page available

10.1200/cci.23.00258 | PMID 39167746 Get It

PURPOSE Patient-centered outcomes (PCOs) are pivotal in cancer treatment, as they directly reflect patients' quality of life. Although multiple studies suggest that factors affecting breast cancer–related morbidity and survival are influenced by treatment side effects and adherence to long-term treatment, such data are generally only available on a smaller scale or from a single center. The primary challenge with collecting these data is that the outcomes are captured as free text in clinical narratives written by clinicians. MATERIALS AND METHODS Given the complexity of PCO documentation in these narratives, computerized methods are necessary to unlock the wealth of information buried in unstructured text notes that often document PCOs. Inspired by the success of large language models (LLMs), we examined the adaptability of three LLMs, GPT-2, BioGPT, and PMC-LLaMA, on PCO tasks across three institutions, Mayo Clinic, Emory University Hospital, and Stanford University. We developed an open-source framework for fine-tuning LLM that can directly extract the five different categories of PCO from the clinic notes. RESULTS We found that these LLMs without fine-tuning (zero-shot) struggle with challenging PCO extraction tasks, displaying almost random performance, even with some task-specific examples (few-shot learning). The performance of our fine-tuned, task-specific models is notably superior compared with their non–fine-tuned LLM models. Moreover, the fine-tuned GPT-2 model has demonstrated a significantly better performance than the other two larger LLMs. CONCLUSION Our discovery indicates that although LLMs serve as effective general-purpose models for tasks across various domains, they require fine-tuning when applied to the clinician domain. Our proposed approach has the potential to lead more efficient, adaptable models for PCO information extraction, reducing reliance on extensive computational resources while still delivering superior performance for specific tasks.
From the Editor-in-Chief’s Desk: Are Omega-3 Fatty Acid Supplements an Effective, Safe, and Scalable Treatment for Depression in Children and Adolescents?
Croarkin, Paul E. , Croarkin, Paul E

Journal of Child and Adolescent Psychopharmacology | August 21, 2024 | Volume: 34 | Issue: 7 | Pages: 280-281

10.1089/cap.2024.0075 | PMID 39166747 Get It